Use of fertility preservation services in male reproductive-aged cancer patients
| Autor: | Jason D. Wright, Paula C. Brady, Yongmei Huang, S. Zev Williams, Dawn L. Hershman, Jessica Selter, Alexander Melamed |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Infertility
medicine.medical_specialty Colorectal cancer Short Communication media_common.quotation_subject Fertility 03 medical and health sciences Prostate cancer 0302 clinical medicine medicine Fertility preservation procedure Fertility preservation Testicular cancer RC254-282 media_common Cancer Cryopreservation 030219 obstetrics & reproductive medicine Obstetrics business.industry Reproduction Obstetrics and Gynecology Neoplasms. Tumors. Oncology. Including cancer and carcinogens Gynecology and obstetrics medicine.disease Sperm Oncology 030220 oncology & carcinogenesis RG1-991 business |
| Zdroj: | Gynecologic Oncology Reports, Vol 36, Iss, Pp 100716-(2021) Gynecologic Oncology Reports |
| ISSN: | 2352-5789 |
| Popis: | Highlights • Fertility preservation services are utilized in 9% of reproductive age males with cancer. • While use of fertility preservation services is increasing, rates of use remain modest. • Younger age men and those receiving chemotherapy and radiation are more likely to utilize fertility preservation services. While fertility preservation is a major concern among reproductive age cancer patients, little is known about access and use of fertility preserving services. We examined use of fertility preserving services among men with common solid tumors. A total of 3648 men age 18–40 including 2610 (71.6%) with testicular cancer, 939 (25.7%) with colorectal and 99 (2.7%) with prostate cancer were identified. Fertility preservation services were utilized in 9.3% of men overall including 4.1% who underwent fertility evaluation only and 7.8% who had a fertility preservation procedure. The rate of fertility preservation services rose from 6.6% (95%CI, 3.2–10.0) in 2008 to 12.4% (95%CI, 7.3–17.5) in 2017 (P = 0.04). Use of fertility preservation service was more common in patients with testicular (11.6%, aRR = 3.31; 95% CI 2.22–4.92) and prostate cancer (6.1%, aRR = 3.14; 95% CI 1.28–7.70) compared to those with colon cancer (3.4%). Younger men were more likely to utilize fertility preservation services. 11.5% of men age ≤ 35 years vs. 5.2% of men 36–40 used these services (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|